<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">647</article-id><article-id pub-id-type="doi">10.36691/RJA647</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Sertaconazole in treatment of atopic dermatitis patients</article-title><trans-title-group xml:lang="ru"><trans-title>Эффективность сертаконазола в комплексной терапии атопического дерматита</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Elisyutina</surname><given-names>O G</given-names></name><name xml:lang="ru"><surname>Елисютина</surname><given-names>Ольга Гурьевна</given-names></name></name-alternatives><email>el-olga@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedenko</surname><given-names>E S</given-names></name><name xml:lang="ru"><surname>Феденко</surname><given-names>Е С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shtirbul</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Штырбул</surname><given-names>О В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ «ГНЦ Институт иммунологии ФМБА» России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2013</year></pub-date><volume>10</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2013)</issue-title><issue-title xml:lang="ru">№2 (2013)</issue-title><fpage>66</fpage><lpage>73</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, Фармарус Принт Медиа</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2015-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/647">https://rusalljournal.ru/raj/article/view/647</self-uri><abstract xml:lang="en"><p>The role of Malassezia and Candida infection in pathogenesis of atopic dermatitis, as well as the results of Sertaconazole cream efficiency in atopic dermatitis are given in the article.</p></abstract><trans-abstract xml:lang="ru"><p>В статье обсуждается роль грибковой инфекции, в частности грибов рода Malassezia, Candida, в патогенезе атопического дерматита (АтД), а также данные о целесообразности применения противогрибковой терапии при данном заболевании. Приведены результаты собственных наблюдений об эффективности применения крема сертаконазола в комплексной терапии АтД.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Malassezia</kwd><kwd>Candida</kwd><kwd>atopic dermatitis</kwd><kwd>Malassezia</kwd><kwd>Candida</kwd><kwd>antifungal treatment</kwd><kwd>sertaconazole</kwd><kwd>antihistamine therapy</kwd><kwd>levocetirizine</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>противогрибковая терапия</kwd><kwd>сертаконазол</kwd><kwd>антигистаминная терапия</kwd><kwd>левоцетиризин</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Cork M.J., Danby S.G., Vasilopoulos Y. et al. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 2009, v. 129, p. 1892-1908.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Voegeli R., Rawlings A.V., Breternitz M. et al. Increased stratum corneum serine protease activity in acute eczematous atopic skin. Br. J. Dermatol. 2009, v. 161, p. 70-77.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Beck L.A. Atopic dermatitis: a disease caused by innate immune defects? J. Invest. Dermatol. 2009, v. 129, p. 14-30.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Werfel T. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J. Invest. Dermatol. 2009, v. 129, p. 1878-1891.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Baker B.S. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 2006, v. 144, p. 1-9.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Faergemann J. Atopic dermatitis and fungi. Clin. Microbiol. Rev. 2002, v. 15, p. 545-563.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Savolainen J., Lammintausta K., Kalimo K., Viander M. Candida albicans and atopic dermatitis. Clin. Exp. Allergy.1993, v. 23, p. 332-339.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Darabi K., Hostetler S.G., Bechtel M.A. et al. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J. Am. Acad. Dermatol. 2009, v. 60, p. 125.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Travers J.B., Norris D.A. Johansson C. et al. Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br. J. Dermatol. 2003, v. 148, p. 479-488.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gaitanis G., Magiatis P, Hantschke M. et al. The Malassezia genus in skin and systemic diseases. Clin. Microbiol. Rev. 2012, v. 25, p. 106-141.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Chang F.Y., Lee J.H., Yang Y.H. et al. Analysis of the serum levels of fungi-specific immunoglobulin E in patients with allergic diseases. Int. Arch. Allergy Immunol. 2011, v. 154, p. 49-56.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Mayser P., Gross A. IgE antibodies to Malassezia furfur, Malassezia symbodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborreic eczema orpitiriasis ver-sicolor. Acta Derm. Venerol. 2000, v. 80, p. 357-361.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Casagrande B.F., Fluckiger S., Linder M.T et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsicatopic eczema. J. Invest. Dermatol. 2006, v. 126, p. 2414-2421.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rokeyo M., Tagami H., Usuba Y., Tomita Y. Contact sensitivity to Pityrpsporum ovale in patients with atopic dermatitis. Arch. Dermatol. 1990, v. 126, p. 627-632.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Back O., Schagneus A., Johansson S.G. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch. Dermatol. Reserch. 1995, v. 287, p. 448-451.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kolmer H.L., Taketomi E.A., Hazen K.C. et al. Effect of combined antibakterial and antifun gal treatment in severe atopic dermatitis. J. Allergy Clin. Lmmunol. 1996, v. 98.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Tajima M. Malassezia species in patients with seborrheic dermatitis and atopic dermatitis. Nippon Ishinkin Gakkai Zasshi. 2005, v. 46 (3), p. 163-167.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Сергеев А.Ю., Сергеев А.В. Грибковые инфекции. М., Бином. 2004, с. 188-189.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Jowkar F., Saki N., Alyasin S. Comparison of sertaconazol 2% cream versus hydrocortison 1% ointment in the treatment of atopic dermatitis. J. Dermatilog. Treat. 2013, Mar 8 [Epub aheard of priat].</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venerol. 1980, v. 92, p. 44-47.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Europian Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology. 1993, v. 186, p. 23-31.</mixed-citation></ref></ref-list></back></article>
